NCT03167723View on ClinicalTrials.gov

Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

NACompletedINTERVENTIONAL

Enrollment

193

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions

HemothoraxHemopneumothorax; TraumaticEmpyemaChest Tube Size

Interventions

DEVICE

Chest tube placement

Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.

Trial Locations (1)

28203

Carolinas Medical Center, Charlotte

All Listed Sponsors

lead

Wake Forest University Health Sciences

OTHER

NCT03167723 - Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions | Biotech Hunter | Biotech Hunter